Health
FDA Panel Endorses Grail Blood Test for Cancer Screening
An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer. The benefits are said to outweigh the risks.
Coverage timeline — 1 article
STAT News
An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.
2026-09-23 21:47 UTC